A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

Clinical trial NCT00207688 · COMPLETED

Trial details

NCT number: NCT00207688
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Ulcerative Colitis

Start date: 2004-08-31
Primary completion: 2015-09-09
Enrollment: 505

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.